Jobs / United States / Astrazeneca Pharmaceuticals Lp
Director, RDU IT - Business Partner, Global Medical Affairs IT
Astrazeneca Pharmaceuticals Lp · 🇺🇸 US - Cambridge Kendall SQ - MA
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles1 certified filing for “Global Development Medical Director” (Medical Scientists, Except Epidemiologists) in NY: $331k–$331k, median $331k. Most were filed at wage level II (100%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Astrazeneca Pharmaceuticals Lp
The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Astrazeneca Pharmaceuticals Lp →
About the role
Role Overview As Director, IT Business Partner – Global Medical Affairs , you will serve as the primary IT leader interfacing with Medical Affairs in the Rare Disease Unit (RDU). In this strategic role, you will drive the development and execution of a forward-looking technology roadmap for Medical, championing digital transformation, continuous improvement, and operational excellence. By proactively identifying opportunities for innovation and supporting Medical’s evolving scientific, clinical, and business priorities, you will ensure that Medical is equipped with modern, efficient, and compliant technology solutions that advance scientific engagement and patient outcomes. You will also help identify and progress practical Generative AI and Predictive AI opportunities, working with Enterprise Data & AI, Architecture, Quality, Privacy, Security, and business teams to support responsible adoption, measurable value, and effective human–AI collaboration. Accountabilities • Strategic partnership : Act as a trusted advisor and thought partner to Global Medical Affairs leadership, translating business strategy and needs into actionable technology initiatives. • Technology roadmap : Build and maintain a comprehensive Medical IT roadmap aligned with RDU priorities and the global enterprise IT strategy. • Program delivery : Lead the successful delivery of Medical IT projects and programs, including business process improvements, data integration, and system digitization, while ensuring quality, timeliness, and regulatory compliance, including GxP, privacy, and security requirements. • Business cases and value realization : Facilitate the development of business cases, value-realization plans, and executive communications to support technology investments across Medical. Partner on cross-functional initiatives with Commercial, R&D, and enabling functions. • Innovation and emerging technologies : Drive the evaluation and adoption of innovative technologies, including digital health, data analytics, and AI, to address critical Medical business challenges and improve Medical-to-Market capabilities. • AI use cases and pilots : Partner with business and technical teams to translate priority use cases into appropriately governed pilots and scalable solutions, with clear success measures, user feedback, and value-realization plans. • Responsible AI delivery : Apply company AI governance, data privacy, security, GxP, and validation requirements across the solution lifecycle. Escalate higher-risk use cases to the appropriate governance and assurance forums. • Data readiness and governance : Work with Medical, Data & AI, and data-owner teams to improve the readiness, quality, governance, and appropriate reuse of priority data for analytics and AI, aligned with FAIR principles where applicable. • AI-enabled ways of working : Enable adoption of AI-assisted ways of working through role-based AI literacy, change management, user support, and transparent communications that build confidence while maintaining appropriate human oversight and accountability. • Performance measurement : Define and monitor practical measures for AI-enabled initiatives, including adoption, usability, quality, efficiency, stakeholder outcomes, and realized business value. Use results to guide iteration or retirement. • Change management and adoption : Oversee effective change management, communications, and solution adoption across diverse Medical teams and stakeholders. • Stakeholder and vendor relationships : Maintain and develop collaborative relationships across AstraZeneca/Alexion IT, the broader RDU, and external partners and vendors. • Continuous improvement : Lead post-implementation reviews and lessons learned to continually enhance project delivery and